NL-OMON51975
Completed
Phase 2
Targeting the beta-2 adrenergic pathway to improve skeletal muscle glucose uptake in obese humans - Obese human beta-2 adrenergic stimulation and muscle glucose uptake
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversiteit Maastricht
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Male or (postmenopausal; defined as 1 year after the last cycle) female;
- •2\. Age between 40\-75 years;
- •3\. BMI: 25\-35 kg/m2;
Exclusion Criteria
- •1\. Not meeting all inclusion criteria
- •2\. Cardiovascular disease (determined by means of questionnaires, heart
- •rate/blood pressure measurements and an ECG)
- •3\. Respiratory diseases (including asthma, bronchitis and COPD);
- •4\. Unstable body weight (weight gain or loss \> 5 kg in the last three months);
- •5\. Intention to lose or gain body weight (e.g. with caloric restriction or
- •physical activity)
- •6\. Excessive alcohol and/or drug abuse;
- •7\. Hypokalaemia;
- •8\. Hyperthyroidism
Outcomes
Primary Outcomes
Not specified
Similar Trials
Active, not recruiting
Phase 1
Investigation of a new way for sugar uptake by the skeletal muscle in obese humansEUCTR2021-000731-31-NLMaastricht University40
Active, not recruiting
Phase 1
Investigation of a new way for sugar uptake by the skeletal muscle.EUCTR2018-004245-16-NLMaastricht University16
Completed
Phase 2
Targeting the beta-2 adrenergic pathway to improve skeletal muscle glucose uptake in healthy humansdiabetestype 2 diabetes10018424NL-OMON50072niversiteit Maastricht23
Active, not recruiting
Phase 1
Activation of human brown adipose tissue with the use of salbutamolObesity, overweight, lipid- and glucose metabolismMedDRA version: 20.0Level: LLTClassification code 10029885Term: Obesity, unspecifiedSystem Organ Class: 100000004861Therapeutic area: Body processes [G] - Metabolic Phenomena [G03]EUCTR2020-004059-34-NLeiden University Medical Center10
Completed
Not Applicable
The beta-2 adrenergic receptor in human BATNL-OMON27924A10